Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key.

about

Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key.

Item

http://www.wikidata.org/entity/Q47103586

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@en

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@nl

type

Item

label

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@en

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@nl

prefLabel

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@en

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@nl

P1476

Metronomic chemotherapy for no ...... cancer: Selection is the key.

@en

P2093

Connie Rabanal

http://www.w3.org/2001/XMLSchema#string

Henry Gomez

http://www.w3.org/2001/XMLSchema#string

Silvia Neciosup

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Mechanisms of disseminated cancer cell dormancy: an awakening field

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

Tumorigenesis and the angiogenic switch

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

Adjuvant chemotherapy in older women with early-stage breast cancer.

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

The anti-angiogenic basis of metronomic chemotherapy.

P304

437-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V8.I6.437

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rossana Ruiz

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29291168

http://www.w3.org/2001/XMLSchema#string

P932

5740099

http://www.w3.org/2001/XMLSchema#string